- Question ID
-
2014_1073
- Legal act
- Regulation (EU) No 575/2013 (CRR)
- Topic
- Credit risk
- Article
-
197, 198
- COM Delegated or Implementing Acts/RTS/ITS/GLs/Recommendations
- Not applicable
- Article/Paragraph
-
0
- Type of submitter
-
Accounting firm
- Subject matter
-
Eligible collateral for the purpose of credit risk mitigation
- Question
-
Are American Depository Receipt (ADR) and Global Depository Receipt (GDR) considered as equity for the purpose of credit risk mitigation?
- Background on the question
-
Articles 197(1)(f) and 198(1)(a) of Regulation (EU) No. 575/2013 (CRR) lists eligible forms of collateral for the purpose of credit risk mitigation. This enumeration includes equities, in the German version of the CRR translated as “Aktien” (shares), which does not denote the same as equity as the scope of the English term is wider. Therefore we wonder if the CRR is referring to the economic character in this provision, allowing for the usage of GDRs and ADRs or whether it refers to the strict legal definition of Aktie, as a stipulated by e.g. the Austrian Aktiengesetz. If ADRs are stocklisted at a main index, whereas original shares are not, does this harm their eligibility in respect of Article197(1)(f)?
- Submission date
- Final publishing date
-
- Final answer
-
The criteria distinguishing equity exposures from other types of exposures are provided by Article 133(1) or 147(6) of Regulation (EU) No. 575/2013 (CRR), as applicable. These criteria also help to distinguish equities from debt securities under Articles 197 and 198 of the CRR, and should be used for assessing whether the specific instruments in question qualify as equities under Article 197 or 198, as applicable.
If instruments qualify as equities, eligibility is determined by Article 197(1)(f) and Article 198(1)(a) of the CRR, as applicable. Hence, these instruments need to be included in a main index, or where Article 198 CRR is applicable, at least need to be traded on a recognised exchange.
- Status
-
Final Q&A
- Answer prepared by
-
Answer prepared by the EBA.
- Note to Q&A
-
Update 26.03.2021: This Q&A has been reviewed in the light of the changes introduced to Regulation (EU) No 575/2013 (CRR) and continues to be relevant.
Disclaimer
The Q&A refers to the provisions in force on the day of their publication. The EBA does not systematically review published Q&As following the amendment of legislative acts. Users of the Q&A tool should therefore check the date of publication of the Q&A and whether the provisions referred to in the answer remain the same.